AAAAAA

   
Results: 1-7 |
Results: 7
COMPARISON BETWEEN 4 AND 8 CYCLES OF INTENSIVE CHEMOTHERAPY IN ADULT ACUTE MYELOID-LEUKEMIA - A RANDOMIZED TRIAL OF THE FINNISH LEUKEMIA GROUP
Authors: ELONEN E ALMQVIST A HANNINEN A JANSSON SE JARVENTIE G KOISTINEN P KOIVUNEN E LAHTINEN R LEHTINEN M NOUSIAINEN T PELLINIEMI TT RAJAMAKI A REMES K TIMONEN T VILPO J VOLIN L RUUTU T
Citation: E. Elonen et al., COMPARISON BETWEEN 4 AND 8 CYCLES OF INTENSIVE CHEMOTHERAPY IN ADULT ACUTE MYELOID-LEUKEMIA - A RANDOMIZED TRIAL OF THE FINNISH LEUKEMIA GROUP, Leukemia, 12(7), 1998, pp. 1041-1048
LONG-TERM FOLLOW-UP OF ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) - RESULTS OF A RANDOMIZED TRIAL BETWEEN 4 AND 8 CYCLES OF CHEMOTHERAPY
Authors: ELONEN E ALMQVIST A HANNINEN A JANSSON SE JARVENTIE G KOISTINEN P KOIVUNEN E LAHTINEN R LEHTINEN M NOUSIAINEN T PELLINIEMI TT RAJAMAKI A REMES K TIMONEN T VILPO J VOLIN L RUUTU T
Citation: E. Elonen et al., LONG-TERM FOLLOW-UP OF ADULT PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) - RESULTS OF A RANDOMIZED TRIAL BETWEEN 4 AND 8 CYCLES OF CHEMOTHERAPY, British Journal of Haematology, 102(1), 1998, pp. 150-150
INTENSIVE CHEMOTHERAPY OF POOR-PROGNOSIS MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA FOLLOWING MDS WITH IDARUBICIN AND CYTARABINE
Authors: RUUTU T HANNINEN A JARVENTIE G KOISTINEN P KOIVUNEN E KATKA K NOUSIAINEN T OKSANEN K PELLINIEMI TT REMES K TIMONEN T VOLIN L ELONEN E
Citation: T. Ruutu et al., INTENSIVE CHEMOTHERAPY OF POOR-PROGNOSIS MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA FOLLOWING MDS WITH IDARUBICIN AND CYTARABINE, Leukemia research, 21(2), 1997, pp. 133-138
TOLERABILITY AND KINETICS OF A SOLVENT-DETERGENT-TREATED INTRAVENOUS IMMUNOGLOBULIN PREPARATION IN HYPOGAMMAGLOBULINEMIA PATIENTS
Authors: EBELING F BAER M HORMILA P JARVENTIE G KOISTINEN P KATKA K OKSANEN K PERKKIO M RUUTU T SOPPI E VEIJOLA L MYLLYLA G
Citation: F. Ebeling et al., TOLERABILITY AND KINETICS OF A SOLVENT-DETERGENT-TREATED INTRAVENOUS IMMUNOGLOBULIN PREPARATION IN HYPOGAMMAGLOBULINEMIA PATIENTS, Vox sanguinis, 69(2), 1995, pp. 91-94
ORAL INDUCTION AND CONSOLIDATION OF ACUTE MYELOID-LEUKEMIA WITH ETOPOSIDE, 6-THIOGUANINE, AND IDARUBICIN (ETI) IN ELDERLY PATIENTS - A RANDOMIZED COMPARISON WITH 5-DAY TAD
Authors: RUUTU T ALMQVIST A HALLMAN H JARVENPAA E JARVENTIE G KOISTINEN P KOIVUNEN E LAHTINEN R LEHTINEN M NOUSIAINEN T PELLINIEMI TT RAJAMAKI A REMES K SARKKINEN R SINISALO M TIMONEN T VOLIN L ELONEN E
Citation: T. Ruutu et al., ORAL INDUCTION AND CONSOLIDATION OF ACUTE MYELOID-LEUKEMIA WITH ETOPOSIDE, 6-THIOGUANINE, AND IDARUBICIN (ETI) IN ELDERLY PATIENTS - A RANDOMIZED COMPARISON WITH 5-DAY TAD, Leukemia, 8(1), 1994, pp. 11-15
CORTICOSTEROID IS NOT BENEFICIAL IN MULTIPLE-DRUG COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA
Authors: PALVA IP ALAHARJA K ALMQVIST A ELONEN E HALLMAN H HANNINEN A ILVONEN M ISOMAA B JOUPPILA J JARVENPAA E JARVENTIE G KILPI H KOISTINEN P KOIVUNEN E KATKA K KAARIAINEN M LAHTINEN R LAITINEN A LEHTINEN M MAKELA H NYLANDEN P NYMAN D OIVANEN T PELLINIEMI TT PULLI T RAJAMAKI A REMES K ROSENGARD S RUUTU T SOININEN K TIMONEN T WASASTJERNA C VILPO J VOLIN L
Citation: Ip. Palva et al., CORTICOSTEROID IS NOT BENEFICIAL IN MULTIPLE-DRUG COMBINATION CHEMOTHERAPY FOR MULTIPLE-MYELOMA, European journal of haematology, 51(2), 1993, pp. 98-101
INTENSIVE CHEMOTHERAPY OF ADULT AML - A RANDOMIZED TRIAL BETWEEN 4 AND 8 CYCLES
Authors: ELONEN E ALMQVIST A HANNINEN A JANSSON SE JARVENTIE G KOISTINEN P KOIVUNEN E LAHTINEN R LEHTINEN M NOUSIAINEN T PELLINIEMI TT RAJAMAKI A REMES K TIMONEN T VILPO J VOLIN L RUUTU T
Citation: E. Elonen et al., INTENSIVE CHEMOTHERAPY OF ADULT AML - A RANDOMIZED TRIAL BETWEEN 4 AND 8 CYCLES, Blood, 82(10), 1993, pp. 10000328-10000328
Risultati: 1-7 |